# Opportunities for selective reporting of harms in randomized clinical trials: Selection criteria for non-systematic adverse events

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/opportunities-for-selective-reporting-of-harms-in-randomized-clinical-trials/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Evan Mayo‐Wilson,Nicole Fusco,Hwanhee Hong,Tianjing Li,Joseph K. Canner,Kay Dickersin |
| Citations | 35 |
| DOI | 10.1186/s13063-019-3581-3 |
| Fields | Decision Sciences,Medicine,Pharmacology, Toxicology and Pharmaceutics |
| Open Access | true |
| OA Status | gold |
| OA URL | https://trialsjournal.biomedcentral.com/track/pdf/10.1186/s13063-019-3581-3 |
| OpenAlex ID | https://openalex.org/W2972281968 |
| PMID | 31488200 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Nicole Fusco](https://scholariq.org/researchers/nicole-fusco/)

## Paper journal

- [Trials](https://scholariq.org/journals/trials/)

## Paper primary topic

- [Meta-analysis and systematic reviews](https://scholariq.org/topics/meta-analysis-and-systematic-reviews/)

## Paper topics

- [Meta-analysis and systematic reviews](https://scholariq.org/topics/meta-analysis-and-systematic-reviews/)
- [Pharmacovigilance and Adverse Drug Reactions](https://scholariq.org/topics/pharmacovigilance-and-adverse-drug-reactions/)
- [Ethics in Clinical Research](https://scholariq.org/topics/ethics-in-clinical-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.